Age UK

Recent papers from Age UK

1. DDU384: A new preclinical candidate for the treatment of Tuberculosis2026
2. Incidence and prevalence of connective tissue disease (CTD)-associated interstitial lung disease in the United StatesClinical Rheumatology · 2026
3. Association Between Systemic Fluoroquinolones and Risk of Peripheral NeuropathyNeurology · 2026
4. Nonclinical Development of Oligonucleotide-Based Therapeutics: Insights from an IQ DruSafe ONT Working Group SurveyNucleic Acid Therapeutics · 2026
5. Formulations at the Nanoscale: Multi-dimensional Electron Diffraction of Long-Acting Injectable, CabotegravirMolecular Pharmaceutics · 2026
6. Treatment‐driven peripheral blood transcriptomic remodelling and baseline predictors of ESSDAI and STAR response to B‐cell therapy in Sjögren's diseaseArthritis & Rheumatology · 2026
7. Genome-wide mapping of common and rare variant effects on adiposity across childhoodNature Genetics · 2026
8. The case for model-informed vaccine developmentVaccine · 2026
9. Association between number of previous malaria episodes and treatment failure among children and adults with laboratory-confirmed Plasmodium infection treated with pyronaridine-artesunate in Gabon: a retrospective cohort studyMalaria Journal · 2026
10. Applicability of the ICH M7 guidelines for assessing less-than-lifetime exposure to nitrosamine impurities in drug productsRegulatory Toxicology and Pharmacology · 2026
11. Exposure-response and dose simulation of belantamab mafodotin in combination with standards of care in patients with relapsed/refractory multiple myelomaHaematologica · 2026
12. Isolating T‐Cell Potent Lentiviral Vector Subpopulations through Rational Design of Nanofiber Anion‐Exchange AdsorbentsBiotechnology and Bioengineering · 2026
13. A Phase 1 First-Time-in-Human, Open-Label Study of Nelistotug Administered to Patients with Advanced Solid TumorsClinical Cancer Research · 2026
14. Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination–deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trialGynecologic Oncology · 2026
15. Core nucleosomes are refractory to lentiviral DNA integrationNature Communications · 2026
16. Detecting drug-induced nephrotoxicity using simultaneous label-free autofluorescence multiharmonic microscopyToxicological Sciences · 2026
17. Low Analytical Evaluation Threshold in Leachables Screening: Challenges, Potential Solutions and Alternative ApproachesPharmaceutical Research · 2026
18. A quantitative computational framework for particle descriptors of pharmaceutical compoundsPowder Technology · 2026
19. AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine (Adjuvanted RSVPreF3): Review of the First 2 Years of Post-Marketing Safety SurveillanceDrug Safety · 2026
20. Population Pharmacokinetics and Pharmacodynamics of Depemokimab in People with Asthma and Chronic Rhinosinusitis with Nasal PolypsThe Journal of Clinical Pharmacology · 2026